US 11,857,594 B2
Curcumin compositions and methods of use as an NK3 antagonist
James R. Komorowski, Trumbull, CT (US); and Sarah Sylla, Brooklyn, NY (US)
Assigned to JDS Therapeutics, LLC, Harrison, NY (US)
Filed by Bonafide Health, LLC, Harrison, NY (US)
Filed on Oct. 18, 2022, as Appl. No. 17/968,788.
Claims priority of provisional application 63/278,989, filed on Nov. 12, 2021.
Prior Publication US 2023/0149499 A1, May 18, 2023
Int. Cl. A61K 36/00 (2006.01); A61K 36/9066 (2006.01); A61P 15/12 (2006.01); A61K 36/82 (2006.01); A61K 31/26 (2006.01)
CPC A61K 36/9066 (2013.01) [A61K 31/26 (2013.01); A61K 36/82 (2013.01); A61P 15/12 (2018.01)] 12 Claims
 
1. A combination composition comprising an amount of a curcumin composition, an amount of a green tea extract composition, and an amount of a phycocyanin composition, wherein the amount of the curcumin composition, the amount of the green tea extract composition, and the amount of the phycocyanin composition comprise a synergistic ratio.